Background The fucosylated fraction of alpha-fetoprotein (AFP-L3) has been used as a
diagnostic marker for hepatocellular carcinoma (HCC). Recently, a highly sensitive …

Aim The aim of this study was to evaluate the clinical usefulness of measuring the Lens
culinaris agglutinin-reactive fraction of alpha-fetoprotein (AFP-L3) for prognostic predictor in …

Abstract Background and Aim: Fucosylated alpha‐fetoprotein (AFP‐L3) is known to be a
marker of poor prognosis in patients with hepatocellular carcinoma (HCC). However, it has …

Abstract Alpha-fetoprotein (AFP)-L3 was originally reported as a hepatocellular carcinoma
(HCC)-specific tumor marker, and recent accumulation of evidence has revealed that AFP …

Aim: This study aimed to evaluate the fucosylated fraction of alpha-fetoprotein (AFP-L3) as a
marker of early hepatocellular carcinoma (HCC). Patients and Methods: We diagnosed early …

Aim of this study was to establish fucosylation index (FI) of α-fetoprotein (AFP) before and
after initial treatment as a useful prognostic factor in patients with hepatocellular carcinoma …

Abstract Background and Aim: The purpose of the present study was to investigate the
clinical significance of the highly sensitive fucosylated fraction of α‐fetoprotein (hs‐AFP‐L3) …

Background: The aim of the present study was to establish L3 fraction before initial treatment
as a useful prognostic factor in a prospective fashion in hepatocellular carcinoma (HCC) …

BACKGROUND The aim of this study was to elucidate the usefulness of measuring the
fucosylation index (FI) of α‐fetoprotein (AFP) before the initiation of therapy as a new …

Background Alpha-fetoprotein (AFP) has been widely used as a diagnostic master for
hepatocellular carcinoma (HCC), and the fucosylated fraction of AFP (AFP-L3) has been …